Early application of the Ponseti casting technique for clubfoot correction in sick infants at the neonatal intensive care unit

E. Lebel, E. Weinberg, Tamar Berenstein-Weyel, R. Bromiker
{"title":"Early application of the Ponseti casting technique for clubfoot correction in sick infants at the neonatal intensive care unit","authors":"E. Lebel, E. Weinberg, Tamar Berenstein-Weyel, R. Bromiker","doi":"10.1097/BPB.0000000000000363","DOIUrl":null,"url":null,"abstract":"The treatment of congenital clubfoot has been changing rapidly since the mid-1990s with the worldwide use of the Ponseti method for serial casting and limited operative interventions. This method was first applied for isolated clubfeet and later on for other types of clubfoot (teratologic, residual, and neurogenic). Premature babies sustaining clubfoot commonly suffer from additional congenital and acquired medical problems. These may postpone clubfoot management until urgent issues are resolved. The current study describes early initiation of treatment of clubfoot in premature babies at the neonatal intensive care unit (NICU) and their outcomes. The study group included all babies diagnosed with clubfoot and managed in the NICU (for any etiology) between 2006 and 2012. Management was based on the Ponseti protocol for serial casting. We also report on neonates who died in the NICU before or during treatment. We specifically describe adverse events of early casting and situations necessitating removal of casts or termination of treatment. We diagnosed and treated 20 neonates with clubfoot (four females and 16 males, 10 bilateral cases). Gestational age ranged from 27 weeks to term. Eight were identified with clubfoot by prenatal sonographic survey and 10 were diagnosed with a defined syndrome. Seven had respiratory support, including one with a chest drain (50%). Length of stay in the NICU ranged from 3 to 90 days. Four neonates died while in the NICU (all syndromatic). In the remaining 16 cases, treatment began as early as medically possible. The first cast was applied within the first week of life in 14 cases. A total of 75 casts were applied during the study period. Three casts (4%) were removed because of leg edema or a need for venous access. Casts were routinely replaced every 4–7 days. Achilles tenotomies were performed in the NICU for babies achieving satisfactory correction. At last follow-up, 10 children were independent walkers and six were nonambulatory; all showed successful correction of clubfeet. The results of this study show that in most cases, clubfoot treatment is feasible and effective within the first week of life. Instances necessitating immediate cast removal are highlighted. Although while facing acute life-threatening medical problems, the treatment of clubfoot may not be considered a priority, most neonates will grow up into independent individuals; thus, every effort should be made to initiate the best clubfoot management with minimal delay.","PeriodicalId":16709,"journal":{"name":"Journal of Pediatric Orthopaedics B","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Orthopaedics B","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/BPB.0000000000000363","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

The treatment of congenital clubfoot has been changing rapidly since the mid-1990s with the worldwide use of the Ponseti method for serial casting and limited operative interventions. This method was first applied for isolated clubfeet and later on for other types of clubfoot (teratologic, residual, and neurogenic). Premature babies sustaining clubfoot commonly suffer from additional congenital and acquired medical problems. These may postpone clubfoot management until urgent issues are resolved. The current study describes early initiation of treatment of clubfoot in premature babies at the neonatal intensive care unit (NICU) and their outcomes. The study group included all babies diagnosed with clubfoot and managed in the NICU (for any etiology) between 2006 and 2012. Management was based on the Ponseti protocol for serial casting. We also report on neonates who died in the NICU before or during treatment. We specifically describe adverse events of early casting and situations necessitating removal of casts or termination of treatment. We diagnosed and treated 20 neonates with clubfoot (four females and 16 males, 10 bilateral cases). Gestational age ranged from 27 weeks to term. Eight were identified with clubfoot by prenatal sonographic survey and 10 were diagnosed with a defined syndrome. Seven had respiratory support, including one with a chest drain (50%). Length of stay in the NICU ranged from 3 to 90 days. Four neonates died while in the NICU (all syndromatic). In the remaining 16 cases, treatment began as early as medically possible. The first cast was applied within the first week of life in 14 cases. A total of 75 casts were applied during the study period. Three casts (4%) were removed because of leg edema or a need for venous access. Casts were routinely replaced every 4–7 days. Achilles tenotomies were performed in the NICU for babies achieving satisfactory correction. At last follow-up, 10 children were independent walkers and six were nonambulatory; all showed successful correction of clubfeet. The results of this study show that in most cases, clubfoot treatment is feasible and effective within the first week of life. Instances necessitating immediate cast removal are highlighted. Although while facing acute life-threatening medical problems, the treatment of clubfoot may not be considered a priority, most neonates will grow up into independent individuals; thus, every effort should be made to initiate the best clubfoot management with minimal delay.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
早期应用庞氏铸造技术在新生儿重症监护病房的畸形足矫正的患病婴儿
自20世纪90年代中期以来,先天性内翻足的治疗方法发生了迅速的变化,世界范围内使用Ponseti方法进行连续铸造和有限的手术干预。该方法首先应用于分离的内翻足,后来应用于其他类型的内翻足(畸形、残留和神经源性)。患有内翻足的早产儿通常会遭受额外的先天性和后天医学问题。这些可能会推迟内翻足的管理,直到紧急问题得到解决。目前的研究描述了新生儿重症监护病房(NICU)早产儿内翻足的早期治疗及其结果。研究组包括2006年至2012年间所有诊断为内翻足并在新生儿重症监护病房(NICU)治疗的婴儿(任何病因)。管理是基于Ponseti协议的串行铸造。我们还报道了新生儿在治疗前或治疗期间在新生儿重症监护病房死亡的病例。我们具体描述了不良事件的早期铸造和情况下,需要拆除铸件或终止治疗。我们诊断并治疗了20例新生儿内翻足(女4例,男16例,双侧10例)。胎龄从27周到足月不等。通过产前超声检查确定8例为内翻足,10例诊断为明确的综合征。7人接受呼吸支持,其中1人胸腔引流(50%)。在新生儿重症监护室的住院时间为3至90天。4名新生儿在新生儿重症监护室死亡(均为综合征)。在其余16例病例中,在医学上可能的情况下尽早开始治疗。14例患儿在出生后第一周内使用第一次石膏。研究期间共应用了75个铸型。3例(4%)石膏因腿部水肿或需要静脉通道而被移除。每4-7天常规更换一次铸型。在新生儿重症监护病房进行跟腱切断术,获得满意的矫正效果。最后随访时,10名儿童独立行走,6名儿童不能行走;所有患者均成功矫正畸形足。本研究结果表明,在大多数情况下,畸形足治疗在出生后第一周内是可行和有效的。需要立即移除铸型的实例被突出显示。虽然在面临严重危及生命的医疗问题时,治疗内翻足可能不被视为优先事项,但大多数新生儿将成长为独立的个体;因此,应尽一切努力,以最小的延迟开始最好的内翻足管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Analysis of risk factors for nonunion in pediatric lateral column lengthening’ by Torrez et al. A comparison of cone beam computed tomography, standard computed tomography, and plain radiographs in the evaluation of medial epicondyle humerus fractures Letter to the editor, concerning Cimen et al.: ‘Percutaneous release for trigger thumb in children under local anesthesia’ Referral patterns to a pediatric orthopedic clinic: pediatric orthopedic surgeons are primary care musculoskeletal medicine physicians Reliability and validity of Vancouver Scar Scale and Withey score after syndactyly release
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1